Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 8.85
+0.34 (4.00%)
Oct 14, 2026, 12:45 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.36 billion as of October 13, 2026. It is the 15,292nd most valuable company in the world and the 4,182nd biggest in China. Its market cap has decreased by 9.63% in one year.
Market Cap
3.36B
Enterprise Value
3.24B
Revenue
2.85B
Global Rank
Country Rank
#4,182 China
PE Ratio
22.47
ChartMarket Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.36B, an increase of 86.14%. That is a compound annual growth rate of 3.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 3.36B | -1.16% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Serum Bio-Technology | 3.55B |
| Pulike Biological Engineering | 3.50B |
| Shanghai Shen Lian Biomedical | 3.37B |
| Qingdao Vland Biotech INC. | 3.34B |
| Lifecome Biochemistry | 3.25B |
| Jiangsu Bioperfectus Technologies | 3.21B |
| Guanhao Biotech | 3.11B |
| Hinova Pharmaceuticals | 3.05B |